Literature DB >> 17994015

Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA.

Matthew E Klein1, Daniel T Lioy, Lin Ma, Soren Impey, Gail Mandel, Richard H Goodman.   

Abstract

Both increases and decreases in methyl CpG-binding protein 2 (MeCP2) levels cause neurodevelopmental defects. We found that MeCP2 translation is regulated by microRNA 132 (miR132). Block of miR132-mediated repression increased MeCP2 and brain-derived neurotrophic factor (BDNF) levels in cultured rat neurons and the loss of MeCP2 reduced BDNF and miR132 levels in vivo. This feedback loop may provide a mechanism for homeostatic control of MeCP2 expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17994015     DOI: 10.1038/nn2010

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  227 in total

1.  Genome-wide analysis reveals methyl-CpG-binding protein 2-dependent regulation of microRNAs in a mouse model of Rett syndrome.

Authors:  Hao Wu; Jifang Tao; Pauline J Chen; Atif Shahab; Weihong Ge; Ronald P Hart; Xiaoan Ruan; Yijun Ruan; Yi E Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

Review 2.  Heterogeneity and individuality: microRNAs in mental disorders.

Authors:  Leif G Hommers; Katharina Domschke; Jürgen Deckert
Journal:  J Neural Transm (Vienna)       Date:  2014-11-14       Impact factor: 3.575

Review 3.  Complexities of Rett syndrome and MeCP2.

Authors:  Rodney C Samaco; Jeffrey L Neul
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

Review 4.  MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction.

Authors:  Bin Xu; Pei-Ken Hsu; Maria Karayiorgou; Joseph A Gogos
Journal:  Neurobiol Dis       Date:  2012-03-03       Impact factor: 5.996

5.  Acute intermittent hypoxia-induced expression of brain-derived neurotrophic factor is disrupted in the brainstem of methyl-CpG-binding protein 2 null mice.

Authors:  A Vermehren-Schmaedick; V K Jenkins; S J Knopp; A Balkowiec; J M Bissonnette
Journal:  Neuroscience       Date:  2012-01-18       Impact factor: 3.590

Review 6.  Small RNA-mediated gene regulation in neurodevelopmental disorders.

Authors:  Abrar Qurashi; Peng Jin
Journal:  Curr Psychiatry Rep       Date:  2010-04       Impact factor: 5.285

7.  Loss of microRNAs in pyramidal neurons leads to specific changes in inhibitory synaptic transmission in the prefrontal cortex.

Authors:  Ruby Hsu; Claude M Schofield; Cassandra G Dela Cruz; Dorothy M Jones-Davis; Robert Blelloch; Erik M Ullian
Journal:  Mol Cell Neurosci       Date:  2012-06-20       Impact factor: 4.314

8.  Regulation of adrenal and ovarian steroidogenesis by miR-132.

Authors:  Zhigang Hu; Wen-Jun Shen; Fredric B Kraemer; Salman Azhar
Journal:  J Mol Endocrinol       Date:  2017-07-20       Impact factor: 5.098

Review 9.  The involvement of microRNAs in major depression, suicidal behavior, and related disorders: a focus on miR-185 and miR-491-3p.

Authors:  Gianluca Serafini; Maurizio Pompili; Katelin F Hansen; Karl Obrietan; Yogesh Dwivedi; Noam Shomron; Paolo Girardi
Journal:  Cell Mol Neurobiol       Date:  2013-11-09       Impact factor: 5.046

10.  The environmental neurotoxicant PCB 95 promotes synaptogenesis via ryanodine receptor-dependent miR132 upregulation.

Authors:  Adam Lesiak; Mingyan Zhu; Hao Chen; Suzanne M Appleyard; Soren Impey; Pamela J Lein; Gary A Wayman
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.